|
gptkbp:instanceOf
|
gptkb:investor
|
|
gptkbp:assetsUnderManagement
|
over $2 billion
|
|
gptkbp:focusesOn
|
life sciences investments
healthcare investments
|
|
gptkbp:formerName
|
SV Life Sciences
|
|
gptkbp:foundedIn
|
1993
|
|
gptkbp:headquartersLocation
|
gptkb:London
gptkb:United_Kingdom
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
SV Health Investors
|
|
gptkbp:industry
|
private equity
venture capital
|
|
gptkbp:investedIn
|
biotechnology companies
medical device companies
healthcare services companies
|
|
gptkbp:notableInvestment
|
gptkb:NodThera
gptkb:Crescendo_Biologics
gptkb:Artios_Pharma
gptkb:Alnylam_Pharmaceuticals
gptkb:Immunocore
gptkb:Bicycle_Therapeutics
gptkb:Nimbus_Therapeutics
gptkb:Orchard_Therapeutics
gptkb:Pulmocide
gptkb:Kymab
gptkb:Heptares_Therapeutics
gptkb:Aprea_Therapeutics
gptkb:Carrick_Therapeutics
gptkb:Catabasis_Pharmaceuticals
Autifony Therapeutics
Enara Bio
KalVista Pharmaceuticals
Mission Therapeutics
Quanta Dialysis Technologies
Sitryx
TopiVert
Vantia Therapeutics
VaxEquity
Ziarco
|
|
gptkbp:officeLocation
|
gptkb:Boston
gptkb:San_Francisco
|
|
gptkbp:website
|
https://www.svhealthinvestors.com/
|
|
gptkbp:bfsParent
|
gptkb:Catamaran_Bio
gptkb:Kate_Bingham
|
|
gptkbp:bfsLayer
|
7
|